Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEDTRONIC PLC

(MDT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medtronic : Unveils Balloon Catheter in Europe for Treating Coronary Artery Disease

07/26/2021 | 05:58am EDT


ę MT Newswires 2021
All news about MEDTRONIC PLC
09/15MEDTRONIC : BofA Global Healthcare Conference 2021
PU
09/14Medtronic to Seek Acquisitions
CI
09/14MEDTRONIC : Says US Patent Office Rejects Axonics' Challenge to Bladder Device P..
MT
09/13MEDTRONIC : U.S. Patent and Trademark Office Rejects Axonics' Challenge to Medtr..
PR
09/13MEDTRONIC : Collaboration with Mpirik to Address Disparities in Care Associated ..
PR
09/13Medtronic Collaboration with Mpirik to Address Disparities in Care Associated..
CI
09/10MEDTRONIC PLC : Regulation FD Disclosure (form 8-K)
AQ
09/09MEDTRONIC : 2021 Virtual Wells Fargo Healthcare Conference Presentation
PU
09/07MEDTRONIC : Executives to Speak at Upcoming Investor Conferences
AQ
09/07MEDTRONIC : Announces NAVABLATE Study Results Released in Late-Breaking Podium P..
PR
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Financials (USD)
Sales 2022 32 995 M - -
Net income 2022 5 704 M - -
Net Debt 2022 20 694 M - -
P/E ratio 2022 32,4x
Yield 2022 1,87%
Capitalization 173 B 173 B -
EV / Sales 2022 5,88x
EV / Sales 2023 5,51x
Nbr of Employees 90 000
Free-Float 99,7%
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MDT | IE00BTN1Y115 | MarketScreener
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 29
Last Close Price 128,73 $
Average target price 145,92 $
Spread / Average Target 13,4%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Clinical & Regulatory Officer, Senior VP
Richard E. Kuntz Chief Medical & Scientific Officer, Senior VP
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC10.72%174 552
ABBOTT LABORATORIES15.80%224 776
BECTON, DICKINSON AND COMPANY4.69%75 229
HOYA CORPORATION30.10%62 323
ALIGN TECHNOLOGY, INC.34.62%56 839
SARTORIUS STEDIM BIOTECH79.60%56 591